References
- Pamela M, John L, Trent W, et al. Front Neurol. 2020;11:279.
- Marwah A, Jamie M, Jasdeep S, et al. Stem Cells Cloning. 2018;11:85–93.
References
- Laflamme C, McKeever PM, Kumar R, Schwartz J, Kolahdouzan M, Chen CX, You Z, Benaliouad F, Gileadi O, McBride HM, et al. Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72. Elife. 2019;8:e48363.
- Zhang Y, Burberry A, Wang JY, Sandoe J, Ghosh S, Udeshi ND, Svinkina T, Mordes DA, Mok J, Charlton M, et al. The C9ORF72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Develop. 2018;32(13–14),929–43.
- McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137(5):715–30.
- Gao T, Liu T, Ko C, Zhang L, Joo D, Xie X, Zhu L, Li Y, Cheng X, Sun S. Myeloid cell TBK1 restricts inflammatory responses. Proc Natl Acad Sci. 2022;119(4):e2107742119.
References
- Noh M-Y, Kwon M-S, Oh K-W, et al. bioRxiv. 2022; 05.04.490596 (pre-print)
- Butovsky O, Jedrychowski MP, Cialic R, et al. Ann Neurol. 2015;77:75–99
Reference
- Komine O, Yamanaka K. Neuroinflammation in motor neuron disease. Nagoya J Med Sci. 2015;77(4):537–49.
References
- Mueller S, Decker L, Menge S. et al. Mol Neurobiol. 2023;60:3898–910.
- Bleuzé L, Triaca V, Borreca A. et al. Front Mol Biosci. 2021;8:699613.
- Tan Y, Sgobio C, Arzberger T. et al. Acta Neuropathologica, 2020;139:319–45.
- Coyne A, Yamada SB, Bagevalu Siddegowda B. et al. Human Mol Genet. 2015;24:6886–98.
- Blokhuis AM, Koppers M, Groen EJN. et al. Acta Neuropathologica, 2016;132:175–96.
- Freischmidt A, Goswami A, Limm K. et al. Brain. 2021;144:1214–29.
References
- Blokhuis AM, Koppers M, Groen EJN. et al. Acta Neuropathologica, 2016;132:175–96.
- Coyne A, Yamada SB, Bagevalu Siddegowda B. et al. Hum Mol Genet, 2015;24:6886–98.
- Mueller S, Decker L, Menge S. et al. Mol Neurobiol, 2023;60:3898–910.
- Freischmidt A, Goswami A, Limm K. et al. Brain, 2021;144:1214–29.
References
- Gordon D, Dafinca R, Scaber J, et al. Neurobiol Dis. 2019;121:148–62.
- Feneberg E, Gordon D, Thompson AG, et al. Neurobiol Dis. 2020;144:105050.
Reference
- Wang C, Ward ME, Chen R, et al. Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening. Stem Cell Reports. 2017;9(4):1221–33.
References
- Walker AK, Spiller KJ, Ge G, et al. Acta Neuropathol. 2015;130(5):643–60.
- Bashford JA, Wickham A, Iniesta R, et al. Brain Commun. 2020;2(1):fcaa018.
- de Carvalho M, Kiernan MC, Swash M. J Neurol Neurosurg Psychiatry. 2017;88(9):773–9.
- Andersen J, Revah O, Miura Y, et al. Cell. 2020;183(7):1913–29 e26.
- Reber S, Mechtersheimer J, Nasif S, et al. Mol Biol Cell. 2018;29(2):75–83.
References
- Babinchak WM, Haider R, Dumm BK, Sarkar P, Surewicz K, Choi JK, Surewicz WK. The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain. J Biol Chem. 2019;294(16):6306–17.
- Lu S, Hu J, Arogundade OA, Goginashvili A, Vazquez-Sanchez S, Diedrich JK, Gu J, Blum J, Oung S, Ye Q, Yu H. Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nature Cell Biology. 2022;24(9):1378–93.
References
- Konttinen H, Cabral-da-Silva M e C, Ohtonen S, et al. Stem Cell Rep. 2019;13(4):669–83.
- Meyer K, Ferraiuolo L, Miranda CJ, et al. PNAS. 2013;111(2):829–32.
- Du ZW, Chen H, Liu H, et al. Nature Commun. 2015;6(1).
Reference
- Foster AD, Rea SL. The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen Res. 2020;15(12):2186–94.
References
- Foster AD, Flynn LL, Cluning C, et al. Sci Rep. 2021. Jun 1;11(1):11474.
- Davidson JM, Wu SL, Rayner SL, et al. Mol Neurobiol. 2023 Sep; 60(9):5034–5054.
- Davidson JM, Chung RS, Lee A. Neurobiol Dis. 2022 May:166:105653.
- Rayner SL, Yang S, Farrawell NE, et al. Neurobiol Dis. 2022 Jun 1:167:105673.
- Cheng F, De Luca A, Hogan A, et al. Front Mol Neurosci Apr 27:14:627740
Reference
- Venugopal, et al. J Neurosci. 2015;35(2):707–20.
References
- Brandes MS, Gray NE. NRF2 as a therapeutic target in neurodegenerative diseases. ASN Neuro. 2020;12:1759091419899782.
- Komatsu M, Kurokawa H, Waguri S, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010;12(3):213–23.
- Sánchez-Martín P, Komatsu M. p62/SQSTM1 – steering the cell through health and disease. J Cell Sci. 2018;131(21).
Reference
- Watanabe S, Horiuchi M, et al. Neurobiol Dis. 2023;179:106031.
References
- Hayashi S, Amari M, Okamoto K. et al. J Neurol Sci. 2013;331:61–6.
- Fournet N, Garcia-Segura LM, Norman AM. et al. Brain Res. 1986;399;310–6.
- Tateishi T, Yamasaki R, Tanaka M. et al. J Neuroimmnol. 2010;222;76–81.
- Henkel JS, Engelhardt JI, Siklos L. et al. Ann Neurol. 2004;55;221–35.
References
- Pupillo E, Messina P, Guissani G. et al. Ann Neurol. 2014;75(2):287–97.
- Beers DR, Appel SH. et al. Lancet Neurol. 2019;18(2):211–20.
- Dupuis L, Pradat P-F, Ludolph AC. et al. Lancet Neurol. 2011;10(1):75–82.
- Picher-Martel V, Boutej H, Vezina A. et al. Int J Mol Sci. 2023;24(6):5065.
- Nagel G, Peter RS, Rosenbohm A. et al. Sci Rep. 2017;7(1):4374.
- Ferrer-Donato A, Contreras A, Fernandez P. et al. Brain Behav. 2022;12(1):e2465.